EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Rapid Development of Small Rodent Animal Models for Infectious Disease Research Through Vectorized Receptor Molecule Expression

Melanie M Goens iD, Erin L Howard, Bryce M Warner, Leonardo Susta iD, Sarah K Wootton iD

Viruses · 2024

DOI: 10.3390/v16111794 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Melanie M Goens und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada. Hauptthemen laut MEDLINE: Disease Models, Animal, Rodentia, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the government of Saskatchewan through Innovation Saskatchewan and the Ministry of Agriculture and from the Canada Foundation for Innovation through the Major…, a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence and re-emergence of pathogens with pandemic potential has been a persistent issue throughout history. Recent decades have seen significant outbreaks of zoonotic viruses from members of the Coronaviridae, Filoviridae, Paramyxoviridae, Flaviviridae, and Togaviridae families, resulting in widespread infections. The continual emergence of zoonotic viral pathogens and associated infections highlights the need for prevention strategies and effective treatments. Central to this effort is the availability of suitable animal models, which are essential for understanding pathogenesis and assessing transmission dynamics. These animals are also critical for evaluating the safety and efficacy of novel vaccines or therapeutics and are essential in facilitating regulatory approval of new products. Rapid development of animal models is an integral aspect of pandemic response and preparedness; however, their establishment is fraught by several rate-limiting steps, including selection of a suitable species, the logistical challenges associated with sharing and disseminating transgenic animals (e.g., the time-intensive nature of breeding and maintaining colonies), the availability of technical expertise, as well as ethical and regulatory approvals. A method for the rapid development of relevant animal models that has recently gained traction, in large part due to the COVID-19 pandemic, is the use of gene therapy vectors to express human viral receptors in readily accessible laboratory animals to enable virus infection and development of clinical disease. These models can be developed rapidly on any genetic background, making mechanistic studies and accelerated evaluation of novel countermeasures possible. In this review, we will discuss important considerations for the effective development of animal models using viral vector approaches and review the current vector-based animal models for studying viral pathogenesis and evaluating prophylactic and therapeutic strategies, with an emphasis on models of SARS-CoV-2 infection based on the vectorized expression of human angiotensin-converting enzyme 2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease Models, AnimalRodentiaSARS-CoV-2AnimalsHumansCOVID-19MiceGenetic VectorsAngiotensin-Converting Enzyme 2Communicable Diseases

Stichwörter der Autor:innen

adeno-associated virus vectoranimal modelspandemic potentialprophylactic and therapeutic strategiesviral countermeasureszoonotic infections

Substanzen

Angiotensin-Converting Enzyme 2

Autor:innen und Institutionen

  • Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.
  • Vaccine and Infectious Disease Organization, University of Saskatchewan, 120 Veterinary Rd, Saskatoon, SK S7N 5E3, Canada.
  • Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.

ORCID-Profile: Melanie M Goens, Leonardo Susta, Sarah K Wootton

Förderung

  • the government of Saskatchewan through Innovation Saskatchewan and the Ministry of Agriculture and from the Canada Foundation for Innovation through the Major…
  • a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery

Zitieren

APA

Goens, M. M., Howard, E. L., Warner, B. M., Susta, L., & Wootton, S. K. (2024). Rapid Development of Small Rodent Animal Models for Infectious Disease Research Through Vectorized Receptor Molecule Expression. Viruses. https://doi.org/10.3390/v16111794

Vancouver

Goens MM, Howard EL, Warner BM, Susta L, Wootton SK. Rapid Development of Small Rodent Animal Models for Infectious Disease Research Through Vectorized Receptor Molecule Expression. Viruses. 2024. doi:10.3390/v16111794

BibTeX
@article{Goens2024,
  author = {Goens, Melanie M and Howard, Erin L and Warner, Bryce M and Susta, Leonardo and Wootton, Sarah K},
  title = {Rapid Development of Small Rodent Animal Models for Infectious Disease Research Through Vectorized Receptor Molecule Expression},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16111794}
}
Kostenlos starten →